GO:1901189 positive regulation of ephrin receptor signaling pathway: Signaling Axis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901189 describes any process that activates or increases the frequency, rate or extent of ephrin receptor signaling, a cell-contact-dependent communication system.
• Ephrin receptors (EPHA and EPHB families) and their membrane-bound ephrin ligands are key regulators of thymocyte development, bone formation, and tumor progression [2, 5, 7].
• Positive regulation of this pathway can occur through ligand binding, receptor clustering, kinase activation, and crosstalk with other signaling cascades such as IGF-I and TNF-alpha [5, 8].
• Dysregulated ephrin receptor signaling is implicated in cancers including HER2-positive breast cancer, oral squamous cell carcinoma, and primary mediastinal large B-cell lymphoma [1, 4, 7].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of individual Eph/ephrin components in this pathway [3, 6].
• Understanding positive regulation of ephrin receptor signaling offers therapeutic opportunities in oncology, immunology, and bone regeneration [3, 5, 8].
Description
The Gene Ontology term GO:1901189, positive regulation of ephrin receptor signaling pathway, refers to any process that activates or increases the frequency, rate or extent of signaling through ephrin receptors. Ephrin receptors constitute the largest family of receptor tyrosine kinases, comprising EPHA and EPHB subfamilies, and they interact with membrane-anchored ephrin ligands to mediate short-range cell-cell communication [2, 3]. This signaling axis is critical for diverse developmental and homeostatic processes, including thymic selection, bone remodeling, and intestinal epithelial cell positioning [2, 5, 6]. Researchers study positive regulation of ephrin receptor signaling because its dysregulation contributes to multiple pathologies, notably cancer progression and metastasis [4, 7]. For example, the ephrin-A1/EPHA2 axis promotes glutamine metabolism in HER2-positive breast cancer, supporting tumor growth. In oral squamous cell carcinoma, ephrin-B2 reverse signaling regulates lymph node metastasis. Additionally, somatic mutations in IRF4 in primary mediastinal large B-cell lymphoma have been linked to thymic tropism, a process in which Eph/ephrin interactions are known to play a role [1, 2]. Understanding the molecular mechanisms that positively regulate ephrin receptor signaling is therefore essential for identifying therapeutic targets and designing experimental models. This article synthesizes current knowledge based on QuickGO annotations and verified PubMed literature, covering the definition, key genes, regulatory mechanisms, disease associations, and research methodologies including CRISPR-based approaches [3, 5, 8].
positive regulation of ephrin receptor signaling pathway At A Glance
| GO ID | GO:1901189 |
|---|---|
| GO term | positive regulation of ephrin receptor signaling pathway |
| Ontology | biological_process |
| Synonym | activation of Eph receptor signaling pathway; upregulation of ephrin receptor signaling pathway; positive regulation of Eph receptor signaling pathway |
| Major function | Enhances ephrin receptor signaling, which controls cell migration, adhesion, and differentiation [2, 5]. |
| Related receptors | EPHA1-10, EPHB1-6 [2, 3] |
| Related ligands | Ephrin-A1 to A5, Ephrin-B1 to B3 [2, 7] |
| Key downstream pathways | ERK/MAPK, PI3K/AKT, Rho GTPases [5, 8] |
| Disease relevance | Cancer, bone disorders, immune regulation [1, 4, 7] |
What Is GO:1901189?
GO:1901189 is a biological process term defined as any process that activates or increases the frequency, rate or extent of ephrin receptor signaling pathway. In other words, it encompasses molecular events that enhance the transmission of signals initiated by ephrin receptors, which are receptor tyrosine kinases activated by ephrin ligands [2, 3]. This positive regulation can occur at multiple levels, including increased ligand availability, receptor clustering, enhanced kinase activity, or downstream amplification [5, 8].
Why Is positive regulation of ephrin receptor signaling pathway Important in Cell Biology?
Positive regulation of ephrin receptor signaling is critically important because it governs fundamental processes such as cell repulsion, adhesion, and migration, which are essential for tissue development and homeostasis [2, 5]. Dysregulation of this pathway is implicated in cancer progression, metastasis, and immune disorders, making it a prime target for therapeutic intervention [4, 7]. Moreover, understanding how this pathway is positively regulated can inform the development of drugs that modulate Eph/ephrin interactions [3, 8].
• Regulates thymocyte development and T-cell selection in the thymus.
• Controls bone formation and osteogenic differentiation through crosstalk with TNF-alpha and IGF-I signaling [5, 8].
• Promotes tumor growth and metastasis in breast cancer via EPHA2-mediated glutamine metabolism.
• Modulates lymph node metastasis in oral squamous cell carcinoma through ephrin-B2 reverse signaling.
• Influences intestinal epithelial cell positioning and differentiation via Notch signaling.
• Involved in primary mediastinal large B-cell lymphoma through IRF4 mutations and thymic tropism.
• Serves as a potential therapeutic target for kinase-dead EphB6 in cancer.
• Provides a model for studying cell-contact-dependent signaling in development [2, 6].
What Happens During positive regulation of ephrin receptor signaling pathway?
Ligand Binding and Receptor Activation
In simple terms: Ephrin ligands on one cell bind to Eph receptors on another cell, switching the receptor on.
Positive regulation begins with the binding of membrane-bound ephrin ligands to Eph receptors on adjacent cells, leading to receptor dimerization and autophosphorylation. This interaction is unique because both ligand and receptor are membrane-anchored, requiring direct cell-cell contact. In the thymus, Eph/ephrin-mediated interactions are critical for T-cell development, where positive regulation enhances signaling to promote thymocyte selection. Similarly, in bone, ephrin B2 binding to EphB4 activates forward signaling that mediates IGF-I-induced osteogenic differentiation.
Receptor Clustering and Kinase Activation
In simple terms: Multiple receptors group together and activate each other by adding phosphate groups.
Upon ligand binding, Eph receptors cluster into higher-order oligomers, which amplifies autophosphorylation and kinase activity. This clustering is a key step in positive regulation, as it increases the frequency and extent of signaling. For example, EphB6, a kinase-dead receptor, can still modulate signaling through interactions with other Eph receptors, highlighting the complexity of positive regulation. In HER2-positive breast cancer, EPHA2 activation by ephrin-A1 enhances downstream signaling that supports glutamine metabolism.
Downstream Signaling Cascades
In simple terms: Activated receptors trigger a chain of proteins that relay the signal inside the cell.
Activated Eph receptors phosphorylate downstream effectors, including ERK/MAPK and PI3K/AKT pathways, which promote cell migration, proliferation, and survival [5, 8]. In osteogenic differentiation, EphB4/TNFR2/ERK/MAPK signaling comprises a positive feedback axis where TNF-alpha enhances ephrin receptor signaling. Additionally, ephrin-B2 reverse signaling activates Src family kinases to regulate oral squamous cell carcinoma progression. These cascades exemplify how positive regulation amplifies the initial signal.
Crosstalk with Other Signaling Pathways
In simple terms: Ephrin signaling talks to other communication lines in the cell to boost or fine-tune the response.
Positive regulation of ephrin receptor signaling often involves crosstalk with other pathways. For instance, Notch signaling promotes the generation of EphrinB1-positive intestinal epithelial cells, thereby indirectly enhancing ephrin receptor signaling. In bone, IGF-I signaling upregulates ephrin B2/EphB4 interactions to drive endochondral bone formation. In lymphoma, IRF4 mutations may alter thymic tropism, potentially involving Eph/ephrin interactions. Such crosstalk ensures context-dependent positive regulation.
Key Genes Involved in GO:1901189 positive regulation of ephrin receptor signaling pathway
The following genes and proteins are central to the positive regulation of ephrin receptor signaling pathway, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EPHA2 | Receptor tyrosine kinase; mediates ephrin-A1 signaling | Promotes glutamine metabolism in HER2-positive breast cancer |
| EPHB4 | Receptor for ephrin-B2; regulates osteogenic differentiation | Mediates IGF-I and TNF-alpha effects on bone formation [5, 8] |
| EPHB6 | Kinase-dead receptor; modulates signaling | Potential tumor suppressor or oncogene in various cancers |
| EFNA1 | Ligand for EPHA2; activates forward signaling | Regulates tumor metabolism and growth |
| EFNB1 | Ligand for EPHB receptors; involved in intestinal epithelium | Notch signaling promotes EFNB1-positive cells |
| EFNB2 | Ligand for EPHB4; reverse signaling in cancer | Regulates oral squamous cell carcinoma metastasis |
| IRF4 | Transcription factor; mutated in lymphoma | Somatic mutations linked to thymic tropism |
| TNFR2 | Receptor for TNF-alpha; crosstalks with EphB4 | Part of EphB4/TNFR2/ERK/MAPK axis in osteogenesis |
| IGF1 | Growth factor; upregulates ephrin B2/EphB4 | Regulates endochondral bone formation |
| NOTCH1 | Transmembrane receptor; promotes EFNB1 expression | Controls intestinal epithelial cell generation |
| SRC | Kinase; downstream of ephrin-B2 reverse signaling | Mediates cancer progression |
| ERK1/2 | MAP kinases; downstream of EphB4 | Mediates osteogenic differentiation |
| PI3K | Lipid kinase; downstream of EPHA2 | Supports tumor metabolism |
| AKT | Serine/threonine kinase; downstream of PI3K | Promotes cell survival |
| RhoA | GTPase; regulates cytoskeleton | Mediates Eph receptor-dependent cell repulsion |
| CDC42 | GTPase; regulates cell migration | Downstream of ephrin signaling |
| Ephrin-A5 | Ligand for EPHA receptors | Modulates thymocyte development |
How Is positive regulation of ephrin receptor signaling pathway Regulated?
Positive regulation of ephrin receptor signaling is controlled at multiple levels. Ligand expression can be induced by other pathways, such as Notch signaling promoting EFNB1 in intestinal epithelial cells. Receptor clustering and kinase activity are enhanced by crosstalk with growth factor receptors; for example, IGF-I upregulates ephrin B2/EphB4 interactions in bone. TNF-alpha positively regulates EphB4 signaling through TNFR2, forming a feedback loop that amplifies ERK/MAPK activation. Additionally, somatic mutations in IRF4 may alter thymic tropism, potentially affecting Eph/ephrin-mediated interactions in lymphoma. These regulatory mechanisms ensure context-specific enhancement of ephrin receptor signaling.
positive regulation of ephrin receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EPHA2 | HER2-positive breast cancer | Knockout or overexpression in breast cancer cell lines |
| EPHB4 | Osteogenic differentiation disorders | Point mutation or knockout in osteoblast precursors [5, 8] |
| EFNB2 | Oral squamous cell carcinoma metastasis | Knockdown or overexpression in OSCC cells |
| IRF4 | Primary mediastinal large B-cell lymphoma | Knock-in of somatic mutations in lymphoma models |
| EPHB6 | Various cancers | Knockout and rescue in cancer cell lines |
Ephrin Receptor Signaling in Cancer
Dysregulated positive regulation of ephrin receptor signaling contributes to cancer progression. In HER2-positive breast cancer, the ephrin-A1/EPHA2 axis enhances glutamine metabolism, supporting tumor growth. In oral squamous cell carcinoma, ephrin-B2 reverse signaling promotes lymph node metastasis. Additionally, somatic IRF4 mutations in primary mediastinal large B-cell lymphoma are associated with thymic tropism, a process where Eph/ephrin interactions may play a role [1, 2]. Targeting positive regulators of this pathway could offer therapeutic strategies.
Ephrin Signaling in Bone Disorders
Positive regulation of ephrin receptor signaling is essential for bone homeostasis. EphB4/TNFR2/ERK/MAPK axis mediates the positive effect of TNF-alpha on osteogenic differentiation. IGF-I signaling upregulates ephrin B2/EphB4 to regulate endochondral bone formation. Dysregulation may contribute to bone diseases such as osteoporosis or impaired fracture healing.
Ephrin Signaling in Immune Regulation
In the thymus, Eph/ephrin-mediated interactions are critical for T-cell development and selection. Positive regulation of ephrin receptor signaling influences thymocyte migration and differentiation. In lymphoma, IRF4 mutations may alter thymic tropism, highlighting the role of this pathway in immune cell trafficking.
From positive regulation of ephrin receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does EPHA2 promote glutamine metabolism in breast cancer? | EPHA2 knockout in HER2-positive breast cancer cells |
| How does EphB4 mediate TNF-alpha-induced osteogenesis? | EphB4 point mutation or knockout in osteoblasts |
| What is the role of ephrin-B2 reverse signaling in metastasis? | EFNB2 knockdown or overexpression in OSCC cells |
| Does IRF4 mutation affect thymic tropism? | IRF4 knock-in mutations in lymphoma cell lines |
| How does Notch regulate EFNB1 expression? | Notch1 knockout in intestinal epithelial cells |
| Does IGF-I require EphB4 for bone formation? | EphB4 conditional knockout in bone |
How to Study the positive regulation of ephrin receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for pathway activity | Identify positive regulators |
| Phosphoproteomics | Phosphorylation changes | Map signaling cascades |
| Live-cell imaging | Receptor clustering and dynamics | Visualize activation |
| RNA-seq | Transcriptional changes | Discover induced ligands |
| Co-immunoprecipitation | Protein-protein interactions | Detect receptor complexes |
| Flow cytometry | Cell surface expression | Quantify receptor levels |
| Metabolic assays | Glutamine metabolism | Link EPHA2 to metabolism |
| Xenograft models | Tumor growth and metastasis | Test in vivo relevance |
CRISPR-Based Genetic Screens
CRISPR knockout screens can identify positive regulators of ephrin receptor signaling by disrupting candidate genes and measuring changes in downstream pathway activity. For example, a genome-wide screen in cancer cells could reveal modifiers of EPHA2-dependent glutamine metabolism.
Phosphoproteomics
Phosphoproteomic analysis can quantify changes in receptor autophosphorylation and downstream kinase activity upon positive regulation [5, 8]. This method identifies specific tyrosine residues critical for signaling amplification.
Live-Cell Imaging
Live-cell imaging of fluorescently tagged Eph receptors and ephrins can visualize receptor clustering and internalization in real time [2, 6]. This technique reveals spatiotemporal dynamics of positive regulation.
Transcriptomic Profiling
RNA-seq can identify genes whose expression is altered upon positive regulation, such as EFNB1 induction by Notch signaling. This approach uncovers transcriptional networks that enhance ephrin receptor signaling.
How CRISPR Can Be Used to Study GO:1901189 positive regulation of ephrin receptor signaling pathway
Knockout
CRISPR knockout of Eph receptor or ephrin genes can abolish positive regulation, revealing their necessity in processes like osteogenic differentiation or tumor growth [4, 5]. For example, EPHA2 knockout in breast cancer cells reduces glutamine metabolism and tumor growth.
Point Mutation
Introducing point mutations in kinase domains or phosphorylation sites can dissect specific contributions to positive regulation. For instance, mutating EphB4 autophosphorylation sites can test their role in TNF-alpha-induced osteogenesis.
Knock-in
Knock-in of disease-associated mutations, such as IRF4 mutations found in lymphoma, can model altered thymic tropism and Eph/ephrin signaling. This approach provides causal insights into disease mechanisms.
Overexpression
Overexpression of ephrin ligands or receptors can enhance positive regulation and drive phenotypes like metastasis. For example, EFNB2 overexpression in OSCC cells promotes lymph node metastasis.
How EDITGENE Supports positive regulation of ephrin receptor signaling pathway Research
Researchers studying positive regulation of ephrin receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in enhancing pathway activity. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes in this pathway.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of ephrin receptor signaling pathway research.
Frequently Asked Questions About positive regulation of ephrin receptor signaling pathway
What is GO:1901189?
GO:1901189 is the Gene Ontology term for positive regulation of ephrin receptor signaling pathway, defined as any process that activates or increases the frequency, rate or extent of ephrin receptor signaling.
What genes are involved in positive regulation of ephrin receptor signaling?
Key genes include EPHA2, EPHB4, EPHB6, EFNA1, EFNB1, EFNB2, and downstream effectors like ERK and PI3K [3, 4, 5, 7].
How does ephrin receptor signaling get activated?
Activation occurs when membrane-bound ephrin ligands bind to Eph receptors on adjacent cells, causing receptor clustering and autophosphorylation [2, 3].
What diseases are associated with ephrin receptor signaling?
Dysregulation is linked to cancers such as HER2-positive breast cancer and oral squamous cell carcinoma, as well as bone disorders and lymphoma [1, 4, 7].
What is the role of EPHA2 in cancer?
EPHA2 activated by ephrin-A1 promotes glutamine metabolism in HER2-positive breast cancer, supporting tumor growth.
How does EphB4 regulate bone formation?
EphB4 interacts with TNFR2 and ERK/MAPK to mediate TNF-alpha-induced osteogenic differentiation, and with IGF-I signaling to regulate endochondral bone formation [5, 8].
What is the function of EphB6?
EphB6 is a kinase-dead receptor that can still modulate signaling through interactions with other Eph receptors, influencing cancer progression.
How can CRISPR be used to study ephrin receptor signaling?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of individual genes in the pathway [3, 4, 5].
What is ephrin-B2 reverse signaling?
Ephrin-B2 can act as a receptor itself, transmitting signals into the cell upon binding to Eph receptors, and this reverse signaling regulates cancer metastasis.
What methods are used to study positive regulation of ephrin receptor signaling?
Common methods include CRISPR screens, phosphoproteomics, live-cell imaging, and RNA-seq to measure pathway activity and identify regulators [2, 3, 6].
Conclusion
Positive regulation of ephrin receptor signaling pathway (GO:1901189) is a critical biological process that enhances cell-cell communication through Eph receptors and ephrin ligands. Its dysregulation contributes to cancer, bone disorders, and immune pathologies, making it a compelling area of research [1, 4, 5, 7]. Understanding the molecular mechanisms and key genes involved requires robust experimental models, and CRISPR-based approaches offer powerful tools for functional validation [3, 6, 8]. EDITGENE provides comprehensive services to support such research, from knockout to overexpression models and library screening.
References
- 1. Rai S et al.. 2025. Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma.. Blood 146(13):1586-1600 PMID: 40540746
- 2. Muñoz JJ et al.. 2011. Eph/Ephrin-mediated interactions in the thymus.. Neuroimmunomodulation 18(5):271-80 PMID: 21952679
- 3. Strozen TG et al.. 2021. The EphB6 Receptor: Kinase-Dead but Very Much Alive.. Int J Mol Sci 22(15) PMID: 34360976
- 4. Youngblood VM et al.. 2016. The Ephrin-A1/EPHA2 Signaling Axis Regulates Glutamine Metabolism in HER2-Positive Breast Cancer.. Cancer Res 76(7):1825-36 PMID: 26833123
- 5. Zhang Y et al.. 2020. EphB4/ TNFR2/ERK/MAPK signaling pathway comprises a signaling axis to mediate the positive effect of TNF-α on osteogenic differentiation.. BMC Mol Cell Biol 21(1):29 PMID: 32299362
- 6. Koo BK et al.. 2009. Notch signaling promotes the generation of EphrinB1-positive intestinal epithelial cells.. Gastroenterology 137(1):145-55, 155.e1-3 PMID: 19332065
- 7. Sasabe E et al.. 2017. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.. PLoS One 12(11):e0188965 PMID: 29190834
- 8. Wang Y et al.. 2014. Ephrin B2/EphB4 mediates the actions of IGF-I signaling in regulating endochondral bone formation.. J Bone Miner Res 29(8):1900-13 PMID: 24677183
